ReachRxResearch
Home
Research
Sign Up
  1. Home
  2. Research Hub
  3. Divergent complication patterns of type…

Divergent complication patterns of type 2 diabetes in African individuals who are lean versus overweight or obese: a multi-cohort analysis

Diabetologia·August 23Open Access
Endocrinology & MetabolismPractice changingChronic Kidney DiseaseDiabetic RetinopathyHypertensionStrokeType 2 DiabetesMulti-Cohort Cross-Sectional StudyBiguanideInsulin SecretagogueAdultMetformin

Summary

View source

What was studied

This multi-cohort cross-sectional analysis compared complication profiles in African adults with type 2 diabetes who were lean (BMI <25 kg/m²) vs overweight/obese (BMI ≥25 kg/m²), using harmonised individual-level data from the AADM (n=2,790) and RODAM (n=541) cohorts across Ghana, Nigeria, and Kenya.

Key findings

Lean adults had significantly higher prevalence of diabetic retinopathy (pPR 1.36 [95% CI 1.13–1.63]) and stroke (pPR 1.41 [95% CI 1.01–1.99]), but lower hypertension (pPR 0.77 [95% CI 0.71–0.85]) and 10-year CVD risk (pPR 0.85 [95% CI 0.74–0.97]) compared with overweight/obese peers; CKD prevalence did not differ. Body fat percentage mediated up to 92% of these differences.

Study limitations

- Cross-sectional design prevents causal inference or assessment of temporal sequence between phenotype and complications. - Stroke ascertainment relied on self-reported history without subtyping; CKD was defined by eGFR alone without albuminuria, potentially missing early microvascular kidney disease. - Residual confounding from unmeasured variables (medication adherence, healthcare access, true diabetes duration) cannot be excluded.

Clinical implications

Nearly 40% of African adults with type 2 diabetes are lean and show a distinct complication pattern—more microvascular disease (retinopathy, stroke) but less hypertension and macrovascular risk—likely driven by insulin secretory failure rather than insulin resistance. Clinicians managing lean African patients with type 2 diabetes should be alert to this divergent risk profile and the potential inadequacy of insulin-sensitising agents alone.

Related Questions

Explore related topics

What is the best treatment for lean type 2 diabetes in African patients?How does diabetic retinopathy risk differ in lean versus obese patients with type 2 diabetes?What are the complication patterns of lean diabetes in sub-Saharan Africa?

Publication Details

Year
2026
Journal
Diabetologia
Sample Size
n=3,331
Source
View article
Keep scrolling
More content below.
Up Next